Gregory Kirkpatrick

Statistics

Publications

Citations

243

H-Index

Active since

2013

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of North Carolina at Chapel Hill

Gregory Kirkpatrick is an author at University of Colorado Anschutz Medical Campus specializing in medicine, oncology, and tyrosine kinase inhibitors.

Publications per year

2013–2019

Publications

UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models

Deborah DeRyckere, Alisa B. Lee‐Sherick, Madeline G. Huey et al. · Clinical Cancer Research · 2016 · 73 citations · Full text

Medicine, Oncology, Pharmacology +16

Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors

Weihe Zhang, Dehui� Zhang, Michael A. Stashko et al. · Journal of Medicinal Chemistry · 2013 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis

Giovanni Hernandez, Taylor Mills, Jennifer L. Rabe et al. · Haematologica · 2019 · 57 citations · Full text

Medicine, Immunology, Pathology +17

Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia

Alisa B. Lee‐Sherick, Weihe Zhang, Kelly Menachof et al. · Oncotarget · 2015 · 44 citations · Full text

Medicine, Oncology, Pharmacology +15

1–4 of 4